Uncovering poxvirus proteins involved in regulating the IMV to EV transition

揭示参与调节 IMV 到 EV 转变的痘病毒蛋白

基本信息

  • 批准号:
    8282257
  • 负责人:
  • 金额:
    $ 19.19万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-09-11 至 2014-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Poxviruses include a large family of DNA viruses capable of infecting and causing disease in humans. While the most notorious member variola, the causative agent of smallpox, was eradicated from natural infection, there are still concerns about a clandestine release during a biological attack. In addition, monkeypox and other members of the family have raised concern about epizootic infections that are capable of causing epidemic. Poxviruses produce two infectious forms, intracellular mature virus (IMV) and extracellular virus (EV). While IMV make up the majority of progeny, WV is required for efficient cell-to-cell spread and systemic infection. EV are formed by the intracellular envelopment of IMV. Their formation occurs in the cytoplasm of infected cells and only 8 proteins encoded by the virus are known to be unique to the WV form. The long-term goal of this project is to understand the molecular mechanisms employed by orthopoxoviruses to form, transport, and release infectious WV. The immediate goal of this application is to understand what regulates the transition of IMV to EV. Our hypothesis is that the virus encodes a molecular switch that gradually accumulates to sufficient quantities to block the formation of EV thus allowing the accumulation of IMV. Our specific aims are; 1) Investigation of the temporal relationship of the IMV-EV transition, 2) Perform a genetic screen for proteins involved in EV formation/inhibition. The results obtained will provide greater insight into the molecular mechanism poxviruses use to regulate the formation of the two forms of infectious virions and give us a better understanding of poxvirus morphogenesis and egress. PUBLIC HEALTH RELEVANCE: Even though natural occurring smallpox was eradicated, concern for orthopoxviruses, ranging from a clandestine release of smallpox to outbreaks of epizootic infections such as monkeypox, still exist. Understanding the biology of poxviruses is still a priority not only for preventing epidemics but also for understanding basic mechanisms of biology. The results from this study will provide new insights into poxvirus infections, which will provide new targets for antivirals and treatments against their infections.
描述(由申请人提供):痘病毒包括一个能够感染和引起人类疾病的DNA病毒大家族。虽然最臭名昭著的天花病毒,天花的病原体,已经从自然感染中被根除,但人们仍然担心在生物攻击期间秘密释放。此外,猴痘和其他家族成员引起了人们对能够引起流行病的动物传染病的关注。痘病毒产生两种感染形式,细胞内成熟病毒(IMV)和细胞外病毒(EV)。虽然IMV占后代的大部分,但WV是有效的细胞间传播和全身感染所必需的。EV是由IMV的胞内包膜形成的。它们的形成发生在感染细胞的细胞质中,已知只有8种由病毒编码的蛋白质是WV形式所特有的。该项目的长期目标是了解正痘病毒形成、运输和释放感染性WV的分子机制。这个应用程序的直接目标是理解是什么调节了从IMV到EV的转变。我们的假设是,病毒编码了一个分子开关,该开关逐渐积累到足够的数量以阻止EV的形成,从而允许IMV的积累。我们的具体目标是;1)研究IMV-EV转化的时间关系;2)对参与EV形成/抑制的蛋白进行基因筛选。这一结果将进一步揭示痘病毒调控两种传染性病毒粒子形成的分子机制,并使我们更好地了解痘病毒的形态发生和输出。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BRIAN M WARD其他文献

BRIAN M WARD的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BRIAN M WARD', 18)}}的其他基金

Understanding the Function of F13 as a Matrix Protein for Poxvirus Intracellular Envelopment
了解 F13 作为痘病毒细胞内包膜基质蛋白的功能
  • 批准号:
    10594179
  • 财政年份:
    2023
  • 资助金额:
    $ 19.19万
  • 项目类别:
Identifying Poxvirus Receptors
识别痘病毒受体
  • 批准号:
    9809258
  • 财政年份:
    2019
  • 资助金额:
    $ 19.19万
  • 项目类别:
Uncovering poxvirus proteins involved in regulating the IMV to EV transition
揭示参与调节 IMV 到 EV 转变的痘病毒蛋白
  • 批准号:
    8543623
  • 财政年份:
    2012
  • 资助金额:
    $ 19.19万
  • 项目类别:
Proteins Involved in Orthopoxvirus Intracellular Egress
参与正痘病毒细胞内流出的蛋白质
  • 批准号:
    7989661
  • 财政年份:
    2010
  • 资助金额:
    $ 19.19万
  • 项目类别:
Proteins Involved in Orthopoxvirus Intracellular Egress
参与正痘病毒细胞内流出的蛋白质
  • 批准号:
    8066722
  • 财政年份:
    2010
  • 资助金额:
    $ 19.19万
  • 项目类别:
Protein Interactions Involved in Orthopoxvirus Envelopment
参与正痘病毒包膜的蛋白质相互作用
  • 批准号:
    7350933
  • 财政年份:
    2007
  • 资助金额:
    $ 19.19万
  • 项目类别:
Protein Interactions Involved in Orthopoxvirus Envelopment
参与正痘病毒包膜的蛋白质相互作用
  • 批准号:
    7567605
  • 财政年份:
    2007
  • 资助金额:
    $ 19.19万
  • 项目类别:
Protein Interactions Involved in Orthopoxvirus Envelopment
参与正痘病毒包膜的蛋白质相互作用
  • 批准号:
    7755840
  • 财政年份:
    2007
  • 资助金额:
    $ 19.19万
  • 项目类别:
Protein Interactions Involved in Orthopoxvirus Envelopment
参与正痘病毒包膜的蛋白质相互作用
  • 批准号:
    8840138
  • 财政年份:
    2007
  • 资助金额:
    $ 19.19万
  • 项目类别:
Protein Interactions Involved in Orthopoxvirus Envelopment
参与正痘病毒包膜的蛋白质相互作用
  • 批准号:
    7265425
  • 财政年份:
    2007
  • 资助金额:
    $ 19.19万
  • 项目类别:

相似海外基金

Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
  • 批准号:
    23K18186
  • 财政年份:
    2023
  • 资助金额:
    $ 19.19万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
  • 批准号:
    10560883
  • 财政年份:
    2023
  • 资助金额:
    $ 19.19万
  • 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10730692
  • 财政年份:
    2021
  • 资助金额:
    $ 19.19万
  • 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
  • 批准号:
    21K06459
  • 财政年份:
    2021
  • 资助金额:
    $ 19.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10189880
  • 财政年份:
    2021
  • 资助金额:
    $ 19.19万
  • 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
  • 批准号:
    2404261
  • 财政年份:
    2020
  • 资助金额:
    $ 19.19万
  • 项目类别:
    Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10222540
  • 财政年份:
    2020
  • 资助金额:
    $ 19.19万
  • 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10669717
  • 财政年份:
    2020
  • 资助金额:
    $ 19.19万
  • 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
  • 批准号:
    20K10713
  • 财政年份:
    2020
  • 资助金额:
    $ 19.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10174522
  • 财政年份:
    2020
  • 资助金额:
    $ 19.19万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了